Published in
Elsevier, Nuclear Medicine and Biology, 5(37), p. 637-644
DOI: 10.1016/j.nucmedbio.2010.02.008
Links
- ORCID
- ORCID
- Elsevier
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate
Journal article published in 2010 by
Severin Mairinger,
Oliver Langer 
,
Claudia Kuntner,
Thomas Wanek,
Jens P. Bankstahl,
Marion Bankstahl ,
Johann Stanek,
Bernd Dörner,
Florian Bauer,
Christoph Baumgartner,
Wolfgang Löscher,
Thomas Erker,
Markus Müller
,
Claudia Kuntner,
Thomas Wanek,
Jens P. Bankstahl,
Marion Bankstahl ,
Johann Stanek,
Bernd Dörner,
Florian Bauer,
Christoph Baumgartner,
Wolfgang Löscher,
Thomas Erker,
Markus Müller
This paper is available in a repository.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 